Drug Price Hikes Already Found in 2023
Drug Topics
JANUARY 5, 2023
List prices of 450 medications have increased 5% overall at the beginning of 2023. More price hikes are expected.
Drug Topics
JANUARY 5, 2023
List prices of 450 medications have increased 5% overall at the beginning of 2023. More price hikes are expected.
Drug Topics
JANUARY 12, 2023
As many as 10 Humira biosimilars may be on the US market before 2023 is over. AbbVie has taken several steps to protect its revenues, including the launches of Skyrizi and Rinvoq.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JANUARY 18, 2024
In 2023, the FDA approved six vaccines, including 2 for respiratory syncytial virus (RSV), and the first vaccine to prevent the mosquito-borne virus chikungunya.
Drug Topics
JANUARY 10, 2023
Download it and make 2023 your year! This eBook explores technology-based solutions for community pharmacies that simplify workflows for your revenue-driving services and automate mundane record-keeping tasks.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
Explore the limitations of what we know about prescription drug dosing The future of Clinical Research April 12, 2023 at 11:00 am PDT, 2:00 pm EDT, 7:00 pm GMT Learning Objectives: Dose-response curves and patient treatment: How do pharmacologic and toxicologic principles apply to the dosing of drugs in clinical development?
PhRMA
JANUARY 19, 2023
This January, PhRMA joined health care leaders, investors, R&D experts and members of the media at the 2023 J.P. Morgan Health Care Conference in San Francisco, CA. During this week, we discussed ways to improve patient outcomes, access and affordability in our health care system. Here are some highlights from the conference:
PhRMA
JUNE 8, 2023
Last week, I traveled to the American Society of Clinical Oncology’s (ASCO) annual meeting. It’s always an exceptional meeting where the brightest minds in oncology, including researchers, health care providers and industry stakeholders gather to learn about the latest advancements in cancer research and development (R&D).
Let's personalize your content